fenoldopam has been researched along with malondialdehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corcoran, T; Markos, F; Murray, C; Parfrey, N; Shorten, GD; Snow, HM | 1 |
| Yi, X; Yuan, J; Zhang, G | 1 |
2 other study(ies) available for fenoldopam and malondialdehyde
| Article | Year |
|---|---|
Effects of fenoldopam on renal blood flow and its function in a canine model of rhabdomyolysis.
Topics: Animals; Antihypertensive Agents; Creatinine; Disease Models, Animal; Dogs; Female; Fenoldopam; Glycerol; Hemodynamics; Kidney Function Tests; Male; Malondialdehyde; Renal Circulation; Renal Insufficiency; Rhabdomyolysis; Treatment Failure | 2003 |
Renoprotective role of fenoldopam pretreatment through hypoxia-inducible factor-1alpha and heme oxygenase-1 expressions in rat kidney transplantation.
Topics: Animals; Apoptosis; Benzazepines; Blood Urea Nitrogen; Cold Ischemia; Creatinine; Cytoprotection; Disease Models, Animal; Fenoldopam; Heme Oxygenase (Decyclizing); Hypoxia-Inducible Factor 1, alpha Subunit; Infusions, Intravenous; Interleukin-8; Kidney; Kidney Transplantation; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Superoxide Dismutase; Time Factors; Tumor Necrosis Factor-alpha | 2013 |